These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24780059)

  • 1. Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.
    Paulson K; Serebrin A; Lambert P; Bergeron J; Everett J; Kew A; Jones D; Mahmud S; Meloche C; Sabloff M; Sharif I; Storring J; Turner D; Seftel MD
    Br J Haematol; 2014 Sep; 166(5):660-6. PubMed ID: 24780059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
    Micol JB; Raffoux E; Boissel N; Lengliné E; Canet E; Daniel MT; Labarthe Ad; Maarek O; Cassinat B; Adès L; Baruchel A; Degos L; Azoulay E; Dombret H
    Eur J Cancer; 2014 Apr; 50(6):1159-68. PubMed ID: 24440088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
    Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
    Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012.
    Thuler LCS; Pombo-de-Oliveira MS
    Ann Hematol; 2017 Mar; 96(3):355-362. PubMed ID: 27752823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of acute promyelocytic leukemia in Italy. APL Collaborating Group.
    Avvisati G; Mele A; Stazi MA; Vegna ML; Pasquini P; Mandelli F
    Ann Oncol; 1991 Jun; 2(6):405-8. PubMed ID: 1768626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of acute promyelocytic leukaemia.
    Douer D
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):357-67. PubMed ID: 12935956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
    Bally C; Fadlallah J; Leverger G; Bertrand Y; Robert A; Baruchel A; Guerci A; Recher C; Raffoux E; Thomas X; Leblanc T; Idres N; Cassinat B; Vey N; Chomienne C; Dombret H; Sanz M; Fenaux P; Adès L
    J Clin Oncol; 2012 May; 30(14):1641-6. PubMed ID: 22473162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
    Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L
    J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
    Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G
    Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients.
    Varghese C; Liu VY; Immanuel T; Chien N; Green T; Chan G; Theakston E; Kalev-Zylinska M
    Hematology; 2021 Dec; 26(1):215-224. PubMed ID: 33594940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
    Chen Z; Mai W; Li Z; Zhang H; Zheng Y; Hong S; Yang W; Xiao W; Chen Z; Wang S
    Leuk Lymphoma; 2019 Dec; 60(14):3470-3481. PubMed ID: 31305195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group.
    Pulsoni A; Stazi A; Cotichini R; Allione B; Cerri R; Di Bona E; Nosari AM; Pagano L; Recchia A; Ribersani M; Rocchi L; Veneri D; Visani G; Mandelli F; Mele A
    Eur J Haematol; 1998 Nov; 61(5):327-32. PubMed ID: 9855248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
    Elliott MA; Letendre L; Tefferi A; Hogan WJ; Hook C; Kaufmann SH; Pruthi RK; Pardanani A; Begna KH; Ashrani AA; Wolanskyj AP; Al-Kali A; Litzow MR
    Eur J Haematol; 2012 Mar; 88(3):237-43. PubMed ID: 22023492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013.
    Lehmann S; Deneberg S; Antunovic P; Rangert-Derolf Å; Garelius H; Lazarevic V; Myhr-Eriksson K; Möllgård L; Uggla B; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2017 Jun; 31(6):1457-1459. PubMed ID: 28232742
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute promyelocytic leukemia-associated thrombosis.
    Chang H; Kuo MC; Shih LY; Wu JH; Lin TL; Dunn P; Tang TC; Hung YS; Wang PN
    Acta Haematol; 2013; 130(1):1-6. PubMed ID: 23343825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.